S M Alvarez1, A S Miner, B M Browne, P H Ratz. 1. Departments of Biochemistry and Molecular Biology and Pediatrics, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA.
Abstract
BACKGROUND AND PURPOSE: RhoA kinase (ROCK) participates in K(+) depolarization (KCl)-induced Ca(2+) sensitization of contraction. Whether constitutive, depolarization- or Ca(2+)-activated ROCK plays the major role in this signalling system remains to be determined. Here, we determined whether Bay K 8644, a dihydropyridine that promotes Ca(2+) channel clusters to operate in a persistent Ca(2+) influx mode, could cause ROCK-dependent Ca(2+) sensitization. EXPERIMENTAL APPROACH: Renal and femoral artery rings from New Zealand white rabbits were contracted with Bay K 8644. Tissues were frozen and processed to measure active RhoA and ROCK substrate (myosin phosphatase targeting subunit, MYPT1) and myosin light chain (MLC) phosphorylation, or loaded with fura-2 to measure intracellular free Ca(2+) ([Ca(2+)](i)). Effects of selective inhibitors of contraction were assessed in resting (basal) tissues and those contracted with Bay K 8644. KEY RESULTS: Bay K 8644 produced strong increases in [Ca(2+)](i), MLC phosphorylation and tension, but not in MYPT1 phosphorylation. ROCK inhibition by H-1152 abolished basal MYPT1-pT853, diminished basal MLC phosphorylation and inhibited Bay K 8644-induced increases in MLC phosphorylation and tension. MLC kinase inhibition by wortmannin abolished Bay K 8644-induced contraction and increase in MLC phosphorylation but did not inhibit basal MYPT1-pT853. H-1152 and wortmannin had no effect on MYPT1-pT696, but 1 microM staurosporine inhibited basal MYPT1-pT853, MYPT1-pT696 and MLC phosphorylation. CONCLUSIONS AND IMPLICATIONS: These data suggest that the constitutive activities of ROCK and a staurosporine-sensitive kinase regulate basal phosphorylation of MYPT1, which participates along with activation of MLC kinase in determining the strength of contraction induced by the Ca(2+) agonist, Bay K 8644.
BACKGROUND AND PURPOSE:RhoA kinase (ROCK) participates in K(+) depolarization (KCl)-induced Ca(2+) sensitization of contraction. Whether constitutive, depolarization- or Ca(2+)-activated ROCK plays the major role in this signalling system remains to be determined. Here, we determined whether Bay K 8644, a dihydropyridine that promotes Ca(2+) channel clusters to operate in a persistent Ca(2+) influx mode, could cause ROCK-dependent Ca(2+) sensitization. EXPERIMENTAL APPROACH: Renal and femoral artery rings from New Zealand white rabbits were contracted with Bay K 8644. Tissues were frozen and processed to measure active RhoA and ROCK substrate (myosin phosphatase targeting subunit, MYPT1) and myosin light chain (MLC) phosphorylation, or loaded with fura-2 to measure intracellular free Ca(2+) ([Ca(2+)](i)). Effects of selective inhibitors of contraction were assessed in resting (basal) tissues and those contracted with Bay K 8644. KEY RESULTS:Bay K 8644 produced strong increases in [Ca(2+)](i), MLC phosphorylation and tension, but not in MYPT1 phosphorylation. ROCK inhibition by H-1152 abolished basal MYPT1-pT853, diminished basal MLC phosphorylation and inhibited Bay K 8644-induced increases in MLC phosphorylation and tension. MLC kinase inhibition by wortmannin abolished Bay K 8644-induced contraction and increase in MLC phosphorylation but did not inhibit basal MYPT1-pT853. H-1152 and wortmannin had no effect on MYPT1-pT696, but 1 microM staurosporine inhibited basal MYPT1-pT853, MYPT1-pT696 and MLC phosphorylation. CONCLUSIONS AND IMPLICATIONS: These data suggest that the constitutive activities of ROCK and a staurosporine-sensitive kinase regulate basal phosphorylation of MYPT1, which participates along with activation of MLC kinase in determining the strength of contraction induced by the Ca(2+) agonist, Bay K 8644.
Authors: Swapnil Sonkusare; Philip T Palade; James D Marsh; Sabine Telemaque; Aleksandra Pesic; Nancy J Rusch Journal: Vascul Pharmacol Date: 2006-01-20 Impact factor: 5.773
Authors: Andrea Murányi; Dmitry Derkach; Ferenc Erdodi; Andrea Kiss; Masaaki Ito; David J Hartshorne Journal: FEBS Lett Date: 2005-11-09 Impact factor: 4.124
Authors: Melissa Porter; Melissa C Evans; Amy S Miner; Krystina M Berg; Kevin R Ward; Paul H Ratz Journal: Am J Physiol Cell Physiol Date: 2006-01-18 Impact factor: 4.249
Authors: Tammy M Seasholtz; Jennifer Wessel; Fangwen Rao; Brinda K Rana; Srikrishna Khandrika; Brian P Kennedy; Elizabeth O Lillie; Michael G Ziegler; Douglas W Smith; Nicholas J Schork; Joan Heller Brown; Daniel T O'Connor Journal: Hypertension Date: 2006-04-03 Impact factor: 10.190
Authors: Jenny Bain; Lorna Plater; Matt Elliott; Natalia Shpiro; C James Hastie; Hilary McLauchlan; Iva Klevernic; J Simon C Arthur; Dario R Alessi; Philip Cohen Journal: Biochem J Date: 2007-12-15 Impact factor: 3.857
Authors: Lyndsay J Clelland; Brendan M Browne; Silvina M Alvarez; Amy S Miner; Paul H Ratz Journal: J Muscle Res Cell Motil Date: 2011-06-25 Impact factor: 2.698
Authors: Bhupal P Bhetwal; Kenton M Sanders; Changlong An; Danielle M Trappanese; Robert S Moreland; Brian A Perrino Journal: J Physiol Date: 2013-04-22 Impact factor: 5.182
Authors: Bhupal P Bhetwal; Changlong An; Salah A Baker; Kristin L Lyon; Brian A Perrino Journal: J Muscle Res Cell Motil Date: 2013-04-11 Impact factor: 2.698
Authors: Demosthenes G Papamatheakis; Jay J Patel; Quintin Blood; Travis T Merritt; Lawrence D Longo; Sean M Wilson Journal: Pulm Circ Date: 2012 Jan-Mar Impact factor: 3.017